Navigation Links
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
Date:7/31/2008

,458.6) - (2,458.6)

Expenses related to the New River

acquisition - (57.3) - (60.4)

Purchases of long-term investments (0.1) (3.7) (1.1) (5.8)

Purchases of property, plant and

equipment (61.6) (15.7) (89.4) (33.6)

Purchases of intangible assets - (3.6) - (31.8)

Proceeds from disposal of long-term

assets - - 10.3 -

Proceeds/deposits received for sale

of product rights - 9.8 5.0 16.8

Proceeds from disposal of property,

plant and equipment

0.8 - 0.9 -

Returns from equity investments 0.4 1.0 0.4 2.2

________ ________ ________ ________

Net cash used in investing (60.3) (2,481.5) (68.7) (2,525.0)

activities(B)

________ ________ ________ ________

CASH FLOWS FROM FINANCING

ACTIVITIES:

Proceeds from drawings under bank

facility - 1,300.0 - 1,300.0

Repayment of drawings under bank

facility - (1,300.0) - (1,300.0)

Proceeds from issue of 2.75%

convertible bonds due 2014 - 1,100
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...
(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...sive challenges and opportunities for micro and na...anufacturing of the fibres but in the control and ...workshop will focus on the many challenges of fibr...-of-the art surface chemical analysis, including S...damental effects of topography in SIMS and XPS, AF...
...Calif., May 14 VaxGen,Inc. (OTC Bulletin Board: V...guidance on its expected monthly cash expenditures...n on April 9, 2008. VaxGen expects that,its averag...kely to exceed,$1 million, made up of the followin...real estate and facility, estimated at 32% of m...
...dea Biosciences, Inc.,(Nasdaq: RDEA ) today annou...e Company,s lead mitogen-activated ERK kinase (MEK...W) 2008 in San Diego., The oral presentation det... 20, 2008 at 3:30 p.m. Pacific Time Abstract ...Inhibitor Ameliorates Murine Colitis Se...
Other Biology Technology:Micro and Nano Scale Characterization of Fibers 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 3Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008 2
(Date:11/6/2009)...Monell Center and the Chinese Academy of Sciences ...eting on Taste and Smell Research. Organized by Mo...ll be the first international meeting on taste and...f Executive Officer, American Association for the ...Science magazine, will open the meeting with a ple...
(Date:11/4/2009)...reluctant to officially endorse green tea as a can...about its protective effects, including results of...rch , a journal of the American Association for Ca...al cancer. , Vassiliki Papadimitrakopoulo, M.D....cic/Head and Neck Medical Oncology at the Universi...
(Date:11/4/2009)...ns out, hold the power to help militaries and muni...up toxic waste on test sites. , Compounds known ...k in World War II and have been used in military m... are often used to propel tank shells and act like...creased knowledge of their environmentally harmful...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2Genomic research will enable greener cleanup of military explosive test sites 2Scientists use bed bugs own chemistry against them 47664 1Scientists use bed bugs own chemistry against them 47664 2Scientists use bed bugs own chemistry against them 47664 3Scientists use bed bugs own chemistry against them 47664 4Minnesota Healthcare Community to Build State of the Art Health Information Exchange 47660 1Minnesota Healthcare Community to Build State of the Art Health Information Exchange 47660 2New Program May Help Teens at High Risk for Depression 47656 1New Program May Help Teens at High Risk for Depression 47656 2New Program May Help Teens at High Risk for Depression 47656 3
...h team based at Massachusetts General Hospital (MG...ocess of RNA interference (RNAi), a powerful new r...nimals. They used the RNAi process itself to find ...echanism, which someday may help to fight human di...ce and is receiving early online release on the Sc...
... learn to imitate sounds that are not typical of t... of vocal learning in a non-primate terrestrial ma...urther supports the idea that vocal learning is im...ships among animals that separate and reunite over...ats. , Researchers from the Amboseli Trust for Ele...
...Inc. (Nasdaq: NGEN), developer of advanced diagnos....S. Patent No. 6,867,048, "Multiplexed Active Biol...e. The ,048 patent relates to a method of addressi... multiple rows and columns of a microarray. The pa... the voltage associated with each electrode in a l...
Other Biology News:Scientists identify genetic pathways essential to RNA interference 2Elephants imitate sounds as a form of social communication 2Nanogen Issued Patent for Electronic Microarray With Memory 2
...as been demonstrated that oxidative stress is invo...ase, and cancer. Oxidative stress is the condition... physiological antioxidants exist leading to the d...to oxidative stress is through several antioxidant...
...al Human Serum-Single Donor • Human serum is ... be negative by a test for Human Immunodeficiency ...mmunodeficiency Virus (Anti-HIV 1/2), Hepatitis C ...ce Antigen (HbsAg) and Non-reactive by a screening...
...ProteoSpin Detergent Clean-up Micro Kit provides a...al of SDS, Triton X-100 and other detergents from ...umn chromatography using Norgens patented protein ...of processing 2 50 g of either acidic or basic pro...
Customized Profile from Novascreen-a Caliper Life Sciences Company
Biology Products: